Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 24, 2005Clinical Science

Role of resistin in obesity, insulin resistance and Type II diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

CKChristine M. KusminskiThe University of Texas Southwestern Medical CenterPMPhilip G. McTernanGeneral / Preventive / LipidsSKSudhesh KumarNational Council Of Educational Research And Training

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kusminski et al. (2005) studied this question.

synapsesocial.com/papers/6a77f11b576efb0ddaf7c22fhttps://doi.org/10.1042/cs20050078
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Expression of resistin in the adipose tissue is modulatedby various factors including peroxisome proliferator‐activated receptor α2002 · 51 citations
  2. 2Treatment of Periodontal Disease and Control of Diabetes: An Assessment of the Evidence and Need for Future Research2001 · 151 citations
  3. 3Lipopolysaccharide increases resistin gene expression in vivo and in vitro2002 · 155 citations
  4. 4Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin2001 · 1,154 citations
  5. 5Obesity-induced inflammatory changes in adipose tissue2003 · 1,772 citations